Skip to Content

MYLAN I 400 (Imatinib mesylate 400 mg)

Pill with imprint MYLAN I 400 is Orange, Elliptical / Oval and has been identified as Imatinib mesylate 400 mg. It is supplied by Mylan Pharmaceuticals Inc..

Imatinib is used in the treatment of gastrointestinal stromal tumor; chronic myelogenous leukemia; acute lymphoblastic leukemia; dermatofibrosarcoma protuberans; systemic mastocytosis (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN I 400

Imatinib mesylate

Imprint:
MYLAN I 400
Strength:
400 mg
Color:
Orange
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2246

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide